142 related articles for article (PubMed ID: 26117050)
21. Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction.
Picker SM; Oustianskaia L; Schneider V; Gathof BS
Vox Sang; 2009 Jul; 97(1):26-33. PubMed ID: 19302416
[TBL] [Abstract][Full Text] [Related]
22. Effect of recombinant human megakaryocyte growth and development factor coupled with polyethylene glycol on the platelet storage lesion.
Snyder E; Perrotta P; Rinder H; Baril L; Nichol J; Gilligan D
Transfusion; 1999 Mar; 39(3):258-64. PubMed ID: 10204587
[TBL] [Abstract][Full Text] [Related]
23. In vitro quality of apheresis platelets divided into paediatric-sized units and stored in PVC bags plasticised with TOTM, BTHC or DINCH.
Bashir S; Meli A; Cardigan R
Transfus Med; 2018 Oct; 28(5):380-385. PubMed ID: 29644730
[TBL] [Abstract][Full Text] [Related]
24. Effect of Mirasol pathogen reduction technology system on in vitro quality of MCS+ apheresis platelets.
Mastroianni MA; Llohn AH; Akkök ÇA; Skogheim R; Ødegaard ER; Nybruket MJ; Flesland A; Mousavi SA
Transfus Apher Sci; 2013 Oct; 49(2):285-90. PubMed ID: 23820429
[TBL] [Abstract][Full Text] [Related]
25. The release of prion protein from platelets during storage of apheresis platelets.
Bessos H; Drummond O; Prowse C; Turner M; MacGregor I
Transfusion; 2001 Jan; 41(1):61-6. PubMed ID: 11161247
[TBL] [Abstract][Full Text] [Related]
26. The effect of gamma irradiation on the quality of apheresis platelets during storage for 7 days.
Tynngård N; Studer M; Lindahl TL; Trinks M; Berlin G
Transfusion; 2008 Aug; 48(8):1669-75. PubMed ID: 18482187
[TBL] [Abstract][Full Text] [Related]
27. [Activation of random-donor platelet concentrates and platelet prepared from random-donor apheresis collections during storage].
Lin JJ; Fan HH; Ma Q; Feng ML; Shen XF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):458-61. PubMed ID: 12513749
[TBL] [Abstract][Full Text] [Related]
28. Comparative in vitro evaluation of apheresis platelets stored with 100% plasma versus bicarbonated Ringer's solution with less than 5% plasma.
Oikawa S; Sasaki D; Kikuchi M; Sawamura Y; Itoh T
Transfusion; 2013 Mar; 53(3):655-60. PubMed ID: 22804481
[TBL] [Abstract][Full Text] [Related]
29. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
Picker SM; Tauszig ME; Gathof BS
Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
[TBL] [Abstract][Full Text] [Related]
30. Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma.
Zhang JG; Carter CJ; Culibrk B; Devine DV; Levin E; Scammell K; Weiss S; Gyongyossy-Issa MI
Transfusion; 2008 May; 48(5):847-56. PubMed ID: 18298601
[TBL] [Abstract][Full Text] [Related]
31. Extended storage of single-donor apheresis platelets in CLX blood bags: effect of storage on platelet morphology, viability and in vitro function.
Kenney DM; Peterson JJ; Smith JW
Vox Sang; 1988; 54(1):24-33. PubMed ID: 3348019
[TBL] [Abstract][Full Text] [Related]
32. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods.
Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G
Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the in vitro storage properties of Amicus apheresis platelets collected using single- and double-needle procedures from the same donors.
Wagner SJ; Seetharaman S; Kurtz J
Transfusion; 2012 Mar; 52(3):524-8. PubMed ID: 21880047
[TBL] [Abstract][Full Text] [Related]
34. A rest period before agitation may improve some in vitro apheresis platelet parameters during storage.
Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Wagner SJ
Transfusion; 2012 Jul; 52(7):1433-8. PubMed ID: 22211457
[TBL] [Abstract][Full Text] [Related]
35. The effect of ASA on platelet activation during apheresis and on in-vitro properties of stored platelet concentrates.
Zeiler T; Gritzka D; Karger R; Kretschmer V
Transfusion; 2004 Sep; 44(9):1300-5. PubMed ID: 15318852
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
[TBL] [Abstract][Full Text] [Related]
37. Interruption of agitation of platelet concentrates: effects on in vitro parameters.
van der Meer PF; Gulliksson H; Aubuchon JP; Prowse C; Richter E; de Wildt-Eggen J;
Vox Sang; 2005 May; 88(4):227-34. PubMed ID: 15877643
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the in vitro properties of apheresis platelets during 7-day storage after interrupting agitation for one or three periods.
Wagner SJ; Vassallo R; Skripchenko A; Einarson M; Seetharaman S; Moroff G
Transfusion; 2008 Dec; 48(12):2492-500. PubMed ID: 18764829
[TBL] [Abstract][Full Text] [Related]
39. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
[TBL] [Abstract][Full Text] [Related]
40. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
Picker SM; Steisel A; Gathof BS
Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
